Merck | MRK - Net Income


Merck reported EUR659M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Adidas EUR 482M 401M Mar/2026
Adyen EUR 581.56M 100.6M Dec/2025
Akzo Nobel EUR 93M 505M Mar/2026
Alcon AG USD 189M 28M Mar/2026
Amadeus IT EUR 357M 109.5M Mar/2026
Amarin USD -1.22M 6.51M Dec/2025
AstraZeneca USD 3.08B 754M Mar/2026
BASF EUR 927M 367M Mar/2026
Bayer EUR 2.76B 6.52B Mar/2026
Beiersdorf EUR 387M 165M Dec/2025
Covestro EUR -378M 331M Dec/2025
Danone EUR 778M 260M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 118M 209M Mar/2026
Genmab DKK 31M 370M Dec/2025
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
GRIFOLS EUR 73M 25.25M Mar/2026
Henkel EUR 925M 185M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Infineon EUR 297M 41M Mar/2026
Lakefront Biotherapeutics EUR 14.49M 767.65M Mar/2026
Linde USD 1.53B 399M Dec/2025
Lonza CHF 426M 119M Jun/2025
Merck EUR 659M 340M Mar/2026
Novartis USD 3.16B 747M Mar/2026
Philips EUR 151M 244M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
UCB EUR 1.08B 608M Dec/2025